India itself has received more than a third of the nearly 28 million Indian-made AstraZeneca Covid-19 vaccine doses delivered so far by the global programme for poor countries, according to data from Unicef and a source.

Data on Unicef’s website shows that India had received 10m doses of vaccine from Covax, the most of any country. Nigeria is second with about four million doses. Many poor nations entirely reliant on the programme have so far received little or no vaccine.

Hundreds of millions of AstraZeneca doses made under license by the Serum Institute of India form the vast bulk of the initial order for Covax, the global system set up to vaccinate people mainly in poor countries. Fifty million doses were meant to be delivered in April, but much of that order is likely to be delayed by India’s new export restrictions.

Read the full Reuters story here.